Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Diabetes & Metabolic Disorders
Published in: Journal of Diabetes & Metabolic Disorders 1/2015

Open Access 01-12-2015 | Research article

Association between number of comorbid medical conditions and depression among individuals with diabetes; race and ethnic variations

Authors: Maryam Moghani Lankarani, Shervin Assari

Published in: Journal of Diabetes & Metabolic Disorders | Issue 1/2015

Login to get access

Abstract

Background

Medical and psychiatric comorbidities are commonly comorbid with diabetes. Race and ethnicity may, however, modify the link between medical and psychiatric comorbidities in individuals with diabetes. In this study we compared Non-Hispanic Whites, African Americans, and Caribbean Blacks with diabetes for the association between number of comorbid medical conditions and lifetime and 12-month major depressive disorder (MDD) in individuals with diabetes.

Methods

Data came from the National Survey of American Life (NSAL), 2001–2003. We included 603 patients with diabetes (75 non-Hispanic Whites, 396 African Americans, and 131 Caribbean Blacks). Number of comorbid medical conditions was the independent variable, lifetime and 12-month MDD were dependent variables, and age, gender, education, marital status, employment, and body mass index were covariates. Race- and ethnic- specific logistic regressions were used to determine race and ethnic differences in the associations between number of chronic medical conditions and lifetime and 12-month MDD, while the effect of all covariates were controlled.

Results

Number of chronic medical conditions was positively associated with lifetime MDD among non-Hispanic Whites (OR = 1.719, 95 % CI = 1.018 – 2.902) and African Americans (OR = 1.235, 95 % CI = 1.056– 1.445) but not Caribbean Blacks (P > .05). Number of chronic medical conditions was also associated with 12-month MDD among non-Hispanic Whites (OR = 1.757, 95 % CI = 1.119 – 2.759) and African Americans (OR = 1.381, 95 % CI = 1.175 - 1.623) but not Caribbean Blacks (P > .05).

Conclusions

This study shows race- and ethnic- differences in the association between number of medical comorbidities and MDD among patients with diabetes. These findings invite researchers to study the mechanisms behind race- and ethnic- differences in vulnerability and resilience to the mental health effects of chronic medical conditions.
Literature
1.
2.
Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet. 2011;378(9785):31–40.PubMedCrossRef
3.
de Groot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ. Association of depression and diabetes complications: a meta-analysis. Psychosom Med. 2001;63(4):619–30.PubMedCrossRef
4.
Mc Donald S, Sharpe L, Blaszczynski A. The psychosocial impact associated with diabetes-related amputation. Diabet Med. 2014;31(11):1424–30.PubMedCrossRef
5.
de Grauw WJ, van de Lisdonk EH, Behr RR, van Gerwen WH, van den Hoogen HJ, van Weel C. The impact of type 2 diabetes mellitus on daily functioning. Fam Pract. 1999;16(2):133–9.PubMedCrossRef
6.
Ryerson B, Tierney EF, Thompson TJ, Engelgau MM, Wang J, Gregg EW, et al. Excess physical limitations among adults with diabetes in the US population, 1997–1999. Diabetes Care. 2003;26:206–10.PubMedCrossRef
7.
Gregg EW, Beckles GL, Williamson DF, Leveille SG, Langlois JA, Engelgau MM, et al. Diabetes and physical disability among older US adults. Diabetes Care. 2000;23:1272–7.PubMedCrossRef
8.
Volpato S, Blaum C, Resnick H, Ferrucci L, Fried LP, Guralnick JM. Women’s health and aging study. Diabetes Care. 2002;25:678–83.PubMedCrossRef
9.
Coffey JT, Brandle M, Zhou H, Marriott D, Burke R, Tabaei BP, et al. Valuing health-related quality of life in diabetes. Diabetes Care. 2002;25(12):2238–43.PubMedCrossRef
10.
Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care. 2001;24(6):1069–78.PubMedCrossRef
11.
Feinstein AR. The pre-therapeutic classification of co-morbidity in chronic disease. J Chron Dis. 1970;23:455.PubMedCrossRef
12.
Roy T, Lloyd CE. Epidemiology of depression and diabetes: a systematic review. J Affect Disord. 2012;142(Suppl):S8–21.PubMedCrossRef
13.
Long AN, Dagogo-Jack S. Comorbidities of diabetes and hypertension: mechanisms and approach to target organ protection. J Clin Hypertens (Greenwich). 2011;13(4):244–51.PubMedCrossRef
14.
Huang Y, Wei X, Wu T, Chen R, Guo A. Collaborative care for patients with depression and diabetes mellitus: a systematic review and meta-analysis. BMC Psychiatry. 2013;13(1):260.PubMedPubMedCentralCrossRef
15.
Hlatky MA. Comorbidity and outcome in patients with coronary artery disease. J Am Coll Cardiol. 2004;43(4):583–4.PubMedCrossRef
16.
Stewart S. Refractory to medical treatment but not to nursing care: can we do more for patients with chronic angina pectoris? Eur J Cardiovasc Nurs. 2003;2:169–70.PubMedCrossRef
17.
Cleves MA, Sanchez N, Draheim M. Evaluation of two competing methods for calculating Charlson’s comorbidity index when analyzing short-term mortality using administrative data. J Clin Epidemiol. 1997;50(8):903–8.PubMedCrossRef
18.
Assari S. Chronic medical conditions and major depressive disorder: differential role of positive religious coping among African americans, Caribbean blacks and Non-Hispanic whites. Int J Prev Med. 2014;5(4):405–13.PubMedPubMedCentral
19.
Assari S, Moghani Lankarani M, Ahmadi K. Comorbidity influences multiple aspects of well-being of patients with ischemic heart disease. Int Cardiovasc Res J. 2013;7(4):118–23.PubMedPubMedCentral
20.
Assari S. Cross-country variation in additive effects of socio-economics, health behaviors, and comorbidities on subjective health of patients with diabetes. J Diabetes Metab Disord. 2014;13(1):36.PubMedPubMedCentralCrossRef
21.
Hollisaaz MT, Aghanassir M, Lorgard-Dezfuli-Nezad M, Assari S, Hafezie R, Ebrahiminia M. Medical comorbidities after renal transplantation. Transplant Proc. 2007;39(4):1048–50.PubMedCrossRef
22.
Brett T, Arnold-Reed DE, Popescu A, Soliman B, Bulsara MK, Fine H, et al. Multimorbidity in patients attending 2 Australian primary care practices. Ann Fam Med. 2013;11(6):535–42.PubMedPubMedCentralCrossRef
23.
Booth HP, Prevost AT, Gulliford MC. Impact of body mass index on prevalence of multimorbidity in primary care: cohort study. Fam Pract. 2014;31(1):38–43.PubMedCrossRef
24.
Ornstein SM, Nietert PJ, Jenkins RG, Litvin CB. The prevalence of chronic diseases and multimorbidity in primary care practice: a PPRNet report. J Am Board Fam Med. 2013;26(5):518–24.PubMedCrossRef
25.
Stanners MN, Barton CA, Shakib S, Winefield HR. A qualitative investigation of the impact of multimorbidity on GP diagnosis and treatment of depression in Australia. Aging Ment Health. 2012;16(8):1058–64.PubMedCrossRef
26.
Diederichs C, Berger K, Bartels DB. The measurement of multiple chronic diseases–a systematic review on existing multimorbidity indices. J Gerontol A Biol Sci Med Sci. 2011;66(3):301–11.PubMedCrossRef
27.
Salisbury C, Johnson L, Purdy S, Valderas JM, Montgomery AA. Epidemiology and impact of multimorbidity in primary care: a retrospective cohort study. Br J Gen Pract. 2011;61(582):e12–21.PubMedCrossRef
28.
Wells KB, Golding JM, Burnam MA. Chronic medical conditions in a sample of the general population with anxiety, affective, and substance use disorders. Am J Psychiatry. 1989;146(11):1440–6.PubMedCrossRef
29.
Kazemi-Saleh D, Pishgou B, Farrokhi F, Assari S, Fotros A, Naseri H. Gender impact on the correlation between sexuality and marital relation quality in patients with coronary artery disease. J Sex Med. 2008;5(9):2100–6.PubMedCrossRef
30.
Khedmat H, Karami GR, Pourfarziani V, Assari S, Rezailashkajani M, Naghizadeh MM. A logistic regression model for predicting health-related quality of life in kidney transplant recipients. Transplant Proc. 2007;39(4):917–22.PubMedCrossRef
31.
Malekahmadi MR, Rahimzadeh S, Dezfuli Nejad ML, Lankarani MM, Einollahi B, Assari S. Importance of socioeconomic, clinical, and psychological factors on health-related quality of life in adolescents after kidney transplant. Exp Clin Transplant. 2011;9(1):50–5.PubMed
32.
Noohi S, Khaghani-Zadeh M, Javadipour M, Assari S, Najafi M, Ebrahiminia M, et al. Anxiety and depression are correlated with higher morbidity after kidney transplantation. Transplant Proc. 2007;39(4):1074–8.PubMedCrossRef
33.
Azarkeivan A, Hajibeigi B, Alavian SM, Lankarani MM, Assari S. Associates of poor physical and mental health-related quality of life in beta thalassemia-major/intermedia. J Res Med Sci. 2009;14(6):349–55.PubMedPubMedCentral
34.
Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613.PubMedCrossRef
35.
van den Akker M, Buntinx F, Knottnerus JA. Comorbidity or multimorbidity: what’s in a name? A review of literature. Eur J Gen Pract. 1996;2:65.CrossRef
36.
Hudon C, Fortin M, Dubois MF, Almirall J. Comorbidity and glycemia control among patients with type 2 diabetes in primary care. Diabetes Metab Syndr Obes. 2008;1:33–7.PubMedPubMedCentralCrossRef
37.
Gjeilo KH, Wahba A, Klepstad P, Lydersen S, Stenseth R. Health-related quality of life three years after coronary surgery: a comparison with the general population. Scand Cardiovasc J. 2006;40:29–36.PubMedCrossRef
38.
Chan DSK, Chau JPC, Chang AM. Acute coronary syndromes: cardiac rehabilitation programmes and quality of life. J Adv Nurs. 2005;49(6):591–9.PubMedCrossRef
39.
Pirraglia PA, Peterson JC, Russo PW, Charlson ME. Assessment of decline in health-related quality of life among angina-free patients undergoing coronary artery bypass graft surgery. Cardiology. 2003;99:115–20.PubMedCrossRef
40.
Sherman AM, Shumaker SA, Kancler C, Zheng B, Reboussin DM, Legault C, et al. Baseline health-related quality of life in postmenopausal women with coronary heart disease: the estrogen replacement and atherosclerosis (ERA) trial. J Women’s Health. 2003;12(4):351–62.CrossRef
41.
Kennedy MD, Haykowsky M, Daub B, van Lohuizen K, Knapik G, Black B. Effects of a comprehensive cardiac rehabilitation program on quality of life and exercise tolerance in women: a retrospective analysis. Curr Control Trials Cardiovasc Med. 2003;4(1):1–6.PubMedPubMedCentralCrossRef
42.
Echteld MA. Modeling predictors of quality of life after coronary angioplasty. Allnals of Behav Med. 2003;26(J):49–60.CrossRef
43.
Rumsfeld JS, Ho PM, Magid DJ, McCarthy MJ, Shroyer AL, MaWhinney S, et al. Predictors of health-related quality of life after coronary artery bypass surgery. Ann Thorac Surg. 2004;77:1508–13.PubMedCrossRef
44.
Sundh J, Johansson G, Larsson K, Lindén A, Löfdahl CG, Janson C, et al. Comorbidity and health-related quality of life in patients with severe chronic obstructive pulmonary disease attending Swedish secondary care units. Int J Chron Obstruct Pulmon Dis. 2015;10:173–83.
45.
Chen W, Lynd LD, FitzGerald JM, Marra CA, Rousseau R, Sadatsafavi M. The added effect of comorbidity on health-related quality of life in patients with asthma. Qual Life Res. 2015 Jun 3. [Epub ahead of print] PubMed PMID: 26038225.
46.
Sherman AM, Shumaker SA, Kancler C, Zheng B, Reboussin DM, Legault C, et al. Baseline health-related quality of life in postmenopausal women with coronary heart disease: the estrogen replacement and atherosclerosis (ERA) trial. J Womens Health (Larchmt). 2003;12(4):351–62.
47.
Karlsson I. Sense of coherence: quality of life before and after coronary artery bypass surgery a longitudinal study. J Adv Nurs. 2000;31(6):1383–92.PubMedCrossRef
48.
Westin L, Nilstun T, Carlsson R, Erhardt L. Patients with ischemic heart disease: quality of life predicts long-term mortality. Scand Cardiovasc J. 2005;39(1–2):50–4.PubMedCrossRef
49.
Powell H, Lim LL-Y, Heller RF. Accuracy of administrative data to assess comorbidity in patients with heart disease: an Australian perspective. J Clin Epidemiol. 2001;54:687–93.
50.
American Heart Association. 2003 Heart and stroke statistical update. Dallas, Tex: American Heart Association; 2002.
51.
Baumeister H, Balke K, Ha¨rter M. Psychiatric and somatic comorbidities are negatively associated with quality of life in physically ill patients. J Clin Epidemiol. 2005;58:1090–100.PubMedCrossRef
52.
Assari S. Additive effects of anxiety and depression on body mass index among blacks: role of ethnicity and gender. Int Cardiovasc Res J. 2014;8(2):44–51.PubMedPubMedCentral
53.
Assari S. Separate and combined effects of anxiety, depression and problem drinking on subjective health among Black, Hispanic and Non-Hispanic White men. Int J Prev Med. 2014;5(3):269–79.PubMedPubMedCentral
54.
Assari S. Cross-Country Differences in the Additive Effects of Socioeconomics, Health Behaviors and Medical Comorbidities on Disability among Older Adults with Heart Disease. J Teh Univ Heart Ctr. 2015;10(1):24–33.
55.
Assari S, Lankarani MM, Lankarani RM. Ethnicity modifies the additive effects of anxiety and drug use disorders on suicidal ideation among black adults in the United States. Int J Prev Med. 2013;4(11):1251–7.PubMedPubMedCentral
56.
Assari S. The link between mental health and obesity: role of individual and contextual factors. Int J Prev Med. 2014;5(3):247–9.PubMedPubMedCentral
57.
Assari S. Ethnic and gender differences in additive effects of socio-economics, psychiatric disorders, and subjective religiosity on suicidal ideation among blacks. Int J Prev Med. 2015;6(1):53.PubMedPubMedCentralCrossRef
58.
Assari S, Lankarani MM. Race and ethnic differences in associations between cardiovascular diseases, anxiety, and depression in the United States. Int J Travel Med Glob Health. 2014;2(3):103–9.
59.
60.
61.
Jackson JS, Neighbors HW, Nesse RM, Trierweiler SJ, Torres M. Methodological innovations in the national survey of American life. Int J Methods in Psych Res. 2004;13:289–98.CrossRef
62.
Jackson JS, Torres M, Caldwell CH, Neighbors HW, Nesse RM, Taylor RJ, et al. The national survey of american life: a study of racial, ethnic, and cultural influences on mental disorders and mental health. Int J Methods in Psych Res. 2004;13:196–207.CrossRef
63.
Heeringa S, Wagner J, Torres M, Duan NH, Adams T, Berglund P. Sample designs and sampling methods for the collaborative psychiatric epidemiology studies (CPES). Int J Methods in Psych Res. 2004;13:221–40.CrossRef
64.
65.
Lampe FC, Walker M, Lennon LT, Whincup PH, Ebrahim S. Validity of a self-reported history of doctor-diagnosed angina. J Clin Epidemiol. 1999;52:73–81.PubMedCrossRef
66.
Kessler RC, Andrews G, Mroczek D, Ustun B, Wittchen H. The World Health Organization composite international diagnostic interview short form (CIDI-SF). Int J Methods in Psych Res. 1998;7:171–85.CrossRef
67.
Robins LN, Wing J, Wittchen HU, Helzer JE, Babor TF, Burke J, et al. The composite international diagnostic interview. An epidemiologic instrument suitable for use in conjunction with different diagnostic systems and in different cultures. Arch Gen Psychiatry. 1988;45(12):1069–77.PubMedCrossRef
68.
Wittchen HU. Reliability and validity studies of the WHO–Composite International Diagnostic Interview (CIDI): a critical review. J Psychiatr Res. 1994;28(1):57–84.PubMedCrossRef
69.
Kessler RC, Wittchen HU, Abelson JM, McGonagle K, Schwarz N, Kendler KS, et al. Methodological studies of the Composite International Diagnostic Interview (CIDI) in the US national comorbidity survey (NCS). Int J Methods Psychiatr Res. 1998;7(1):33–55.CrossRef
70.
Kessler RC, Calabrese JR, Farley PA, Gruber MJ, Jewell MA, Katon W, et al. Composite International Diagnostic Interview screening scales for DSM-IV anxiety and mood disorders. Psychol Med. 2013;43(8):1625–37. 85.PubMedCrossRef
71.
Assari S, Lankarani MM, Moazen B. Religious beliefs may reduce the negative effect of psychiatric disorders on age of onset of suicidal ideation among blacks in the United States. Int J Prev Med. 2012;3(5):358–64.PubMedPubMedCentral
72.
Williams DR, Haile R, Gonzalez HM, Neighbors H, Baser R, Jackson JS. The mental health of Black Caribbean immigrants: results from the National Survey of American Life. Am J Public Health. 2007;97(1):52–9.PubMedPubMedCentralCrossRef
73.
Shehatah A, Rabie MA, Al-Shahry A. Prevalence and correlates of depressive disorders in elderly with type 2 diabetes in primary health care settings. J Affect Disord. 2010;123:197–201.PubMedCrossRef
74.
Chen J, Radford MJ, Wang Y, Krumholz HM. Care and outcomes of elderly patients with acute myocardial infarction by physician specialty: the effects of comorbidity and functional limitations. Am J Med. 2000;108:460–9.PubMedCrossRef
75.
Guralink JM. Assessing the impact of comorbidity in the older population. AEP. 1996;6(5):376–80.
76.
Gijsen R, Hoeyymans N, Schellevis FG, Ruwaard D, Satariano WA, van den Bos GA. Causes and consequences of comorbidity: a review. J Clin Epidemiol. 2001;54:661–74.PubMedCrossRef
77.
van Manen JG, Bindels PJE, Dekker FW, IJzermans CJ, van der Zee JS, Schadé E. Risk of depression in patients with chronic obstructive pulmonary disease and its determinants. Thorax. 2002;57:412–6.PubMedPubMedCentralCrossRef
78.
79.
Fryback DG, Lawrence WF. Dollars may not buy as many QALYs as we think: a problem with defining quality-of-life adjustments. Med Decis Mak. 1997;17:276–84.CrossRef
80.
Harris RA, Nease Jr RF. The importance of patient preferences for comorbidities in cost-effectiveness analyses. J Health Econ. 1997;16:113–9.PubMedCrossRef
81.
Bleichrodt H, Crainich D, Eeckhoudt L. The effect of comorbidities on treatment decisions. J Health Econ. 2003;22:805–20.PubMedCrossRef
82.
Kaplan MH, Feinstein AR. The importance of classifying initial comorbidity in evaluating the outcome of diabetes mellitus. J Chron Dis. 1974;27:387–404.PubMedCrossRef
83.
Greenfield S, Aronow HU, Elashoff RM, Watanabe D. Flaws in mortality data: the hazards of ignoring comorbid disease. JAMA. 1988;260:2253–5.PubMedCrossRef
84.
Charlson ME, Pompei PP, Ales KL, MacKenzie CR. A new method of classifying prognostic co-morbidity in longitudinal studies; development and validation. J Chron Dis. 1987;5:373–83.CrossRef
85.
Hlatkey MA, Paul SM, Gortner SR. Functional capacity after cardiac surgery in elderly patients. J Am Co11 Cardiol. 1994;24:104–8.CrossRef
86.
Charlson ME, MacKenzie CR, Gold JP, Ales KL, Topkins M, Shires GT. Risk for postoperative congestive heart failure. Surg Gynecol Obstet. 1991;172:95–104.PubMed
87.
Knaus WA, Wagner DP, Lynn J. Short-term mortality predictions for critically ill hospitalized adults: science and ethics. Science. 1991;254:389–94.PubMedCrossRef
88.
Bayat N, Alishiri GH, Salimzadeh A, Izadi M, Saleh DK, Lankarani MM, et al. Symptoms of anxiety and depression: a comparison among patients with different chronic conditions. J Res Med Sci. 2011;16(11):1441–7.PubMedPubMedCentral
89.
90.
Metadata
Title
Association between number of comorbid medical conditions and depression among individuals with diabetes; race and ethnic variations
Authors
Maryam Moghani Lankarani
Shervin Assari
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Journal of Diabetes & Metabolic Disorders / Issue 1/2015
Electronic ISSN: 2251-6581
DOI
https://doi.org/10.1186/s40200-015-0171-0

Other articles of this Issue 1/2015

Journal of Diabetes & Metabolic Disorders 1/2015 Go to the issue

Research article

Diabetes care among elderly medicare beneficiaries with Parkinson’s disease and diabetes

Research article

The relationship between glycemic control, beta2-microglobulin and inflammation in patients on maintenance dialysis treatment

Research article

Combined association of physical activity and diet with C-reactive protein among smokers

Case report

Recurrent hypoglycaemia in type 2 diabetic patient due to hypothyroidism

Research article

Efficacy and tolerability of vildagliptin as first line treatment in patients with diabetes type 2 in an outpatient setting

Review article

Gestational diabetes mellitus: challenges in diagnosis and management
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits